Fundz

Elegen Raises $35 Million in Series B Led by Triatomic Capital to Accelerate Expansion into Clinical Manufacturing

PRIVATEMay 14, 2024

Amount Raised

$35 Million

Round Type

Series B

San CarlosManufacturingBiotechnology

Investors

Andreessen Horowitz (a16z) Bio + HealthAgilent TechnologiesAME Cloud VenturesAlix VenturesAcvc PartnersDigitalis Ventures8VCKd T VenturesJohn BallantyneGskTriatomic Capital

Description

Elegen, the leader in next-generation DNA synthesis and production, announced a Series B financing of $35 million led by Triatomic Capital. The funds will accelerate the extension of the company’s ENFINIA™ DNA product line across clinical workflows providing turnkey production of GMP-compliant DNA for clinical development of genetic medicines.

Quick answer

Elegen raised $35 Million in a Series B round, dated May 14, 2024. Investors: Andreessen Horowitz (a16z) Bio + Health, Agilent Technologies, AME Cloud Ventures, Alix Ventures, Acvc Partners, Digitalis Ventures, 8VC and Kd T Ventures. Elegen is based in San Carlos, California, United States.

How much did Elegen raise?
Elegen raised $35 Million in a Series B round on May 14, 2024.
Who invested in Elegen?
Andreessen Horowitz (a16z) Bio + Health, Agilent Technologies, AME Cloud Ventures, Alix Ventures, Acvc Partners, Digitalis Ventures, 8VC and Kd T Ventures are named as investors in this round.
What does Elegen do?
Elegen brings unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences.
Where is Elegen based and how big is it?
Elegen is based in San Carlos, California, United States.
Who are the decision-makers at Elegen?
Fundz holds 1 contact at Elegen. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Elegen that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $787K on June 28, 2024.
  • Route 92 Medical raised $50M on June 28, 2024.
  • Phlow raised $5M on June 28, 2024.
  • CASI Pharmaceuticals raised $15M on June 26, 2024.
  • CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
  • TendoNova raised $270K (Seed) on June 26, 2024.

Who to call at Elegen, and when

A new round usually means Elegen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elegen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elegen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elegen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elegen

Location

San Carlos, California, United States

About

Elegen brings unique insights and technical innovation to create high-quality synthetic DNA faster, catalyzing the next revolution in the life sciences. The company is led by seasoned leaders with decades of experience in developing novel and scalable approaches in molecular biology, chemistry and microfluidics. Elegen uses a proprietary microfluidics approach to build longer, higher-quality DNA on a faster timeline for agricultural, chemical, healthcare and pharma industries. Founded in 2017, Elegen is privately held and based in the San Francisco Bay Area.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elegen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Elegen's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Elegen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.